The Group's principal activity is research and development of medicines. The Group conducts research and development in areas like labial herpes, hepatitis C, HIV, osteoporosis, osteoarthritis, skeletal metastases, chronic obstructive pulmonary disease (COPD) and high blood pressure. The Group had 89 patent families and 374 granted patents in force at the close of 2008. The Group operates in the United Kingdom and Sweden.
Alacra Alerts:
Receive alerts on the latest reports on Medivir AB
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
